Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Hydroxyurea for the Treatment of Recurrent and/or Nonoperable Meningioma

NCT00006119 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00006119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Hydroxyurea for the Treatment of Recurrent and/or Nonoperable Meningioma
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1999
Completion date
January 31, 2008
Enrollment
Not reported
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors